Lonsurf 15 MG-6.14 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F4F8N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,686
Award facts
- Contract value 100% obligated
- $16,685.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 27, 2026, for the supply of LONSURF (15 mg-6.14 mg tablet formulation) in a quantity of 60 units, with a firm fixed price ceiling value of $16,685.88 and an ultimate completion date of February 18, 2026. This is a non-set-aside, competitively awarded contract. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The parent organization is Cencora, Inc. (doing business as AmerSourceBergen), which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the underlying vehicle for this delivery order.
LONSURF is an oncology medication used in the treatment of certain cancers, and this delivery order represents one of numerous pharmaceutical product deliveries AmerSourceBergen fulfills under its comprehensive DLA contract. The DLA Medical Supply Chain relies on AmerSourceBergen's extensive pharmaceutical distribution capabilities to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs globally. The company's consistent performance in meeting federal procurement requirements through open competition and firm fixed-price delivery orders demonstrates its capacity to efficiently supply essential medications required by military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4F8N?
SPE2DR26F4F8N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F4F8N worth?
The government has obligated $16,686 on SPE2DR26F4F8N.
Is contract SPE2DR26F4F8N an order under another contract?
Yes. SPE2DR26F4F8N is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F8N competed?
The extent of competition for SPE2DR26F4F8N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award